FRE.AU FIREBRICK PHARMA LTD
Not Yet Opened 12-20 16:12:00 AEDT
0.06
+0.00
+3.70%
High
0.06
Low
0.06
Vol
36.51K
Open
0.06
D1 Closing
0.05
Amplitude
0.00%
Mkt Cap
11.77M
Tradable Cap
5.88M
Total Shares
210.11M
T/O
2.05K
T/O Rate
0.03%
Tradable Shares
104.94M
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Firebrick Pharma Ltd-Consulting Agreement Extended to Grow Asia Sales
THOMSON REUTERS · 12-19
Firebrick Pharma Ltd-Consulting Agreement Extended to Grow Asia Sales
History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?
The Market Herald · 12-12
History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?
Firebrick Pharma launching retail Nasodine sales in Singapore
The Market Herald · 11-25
Firebrick Pharma launching retail Nasodine sales in Singapore
Firebrick Pharma Ltd-Nasodine Retail Pharmacy Launch in Singapore
THOMSON REUTERS · 11-25
Firebrick Pharma Ltd-Nasodine Retail Pharmacy Launch in Singapore
Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico
MT Newswires Live · 11-01
Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico
BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico
Reuters · 11-01
BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico
Firebrick Pharma - Nasodine Covid-19 Patent Allowed in Mexico
THOMSON REUTERS · 11-01
Firebrick Pharma - Nasodine Covid-19 Patent Allowed in Mexico
BRIEF-Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore
Reuters · 10-31
BRIEF-Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore
Firebrick Pharma Ltd - Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore
THOMSON REUTERS · 10-31
Firebrick Pharma Ltd - Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore
Firebrick Pharma Raises Capital via Share Purchase Plan; Shares Up 7%
MT Newswires Live · 10-10
Firebrick Pharma Raises Capital via Share Purchase Plan; Shares Up 7%
Firebrick Pharma Ltd-Firebrick Investor Update Webinar Recording
THOMSON REUTERS · 10-01
Firebrick Pharma Ltd-Firebrick Investor Update Webinar Recording
Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results
MT Newswires Live · 09-25
Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results
Firebrick Pharma Eyes Global Expansion for Nasodine Nasal Spray; Shares Up 8%
MT Newswires Live · 09-25
Firebrick Pharma Eyes Global Expansion for Nasodine Nasal Spray; Shares Up 8%
Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%
MT Newswires Live · 09-17
Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%
Firebrick Pharma Ltd-Share Purchase Plan Open
THOMSON REUTERS · 09-17
Firebrick Pharma Ltd-Share Purchase Plan Open
BRIEF-Firebrick Pharma Announces Share Purchase Plan
Reuters · 09-12
BRIEF-Firebrick Pharma Announces Share Purchase Plan
BUZZ-Australia's Firebrick Pharma tumbles on discounted share purchase plan
Reuters · 09-12
BUZZ-Australia's Firebrick Pharma tumbles on discounted share purchase plan
ASX Small-Cap Stocks to Watch
MT Newswires Live · 09-12
ASX Small-Cap Stocks to Watch
ASX Small-Cap Stocks to Watch
MT Newswires Live · 09-12
ASX Small-Cap Stocks to Watch
Firebrick Pharma Ltd - Share Purchase Plan at an Issue Price of a$0.055 per Share
THOMSON REUTERS · 09-12
Firebrick Pharma Ltd - Share Purchase Plan at an Issue Price of a$0.055 per Share
Load more
Introduction
Company Name.
FIREBRICK PHARMA LTD
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.056,"timestamp":1734671520000,"preClose":0.054,"halted":0,"volume":36514,"delay":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":104941383,"shares":210108508,"eps":-0.006568,"marketStatus":"Not Yet Opened","change":0.002,"latestTime":"12-20 16:12:00 AEDT","open":0.056,"high":0.056,"low":0.056,"amount":2045,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.006568,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1734908400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.054,"openAndCloseTimeList":[[1734649200000,1734670800000]],"volumeRatio":1.213347693383368,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/FRE.AU","defaultTab":"news","newsList":[{"id":"2492315250","title":"Firebrick Pharma Ltd-Consulting Agreement Extended to Grow Asia Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2492315250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492315250?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:30","pubTimestamp":1734557400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUE6LZ4MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2490815738","title":"History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490815738","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490815738?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:51","pubTimestamp":1733953860,"startTime":"0","endTime":"0","summary":"We live in a world that’s only just stopped reeling from the international COVID-19 viral pandemic.The same world where microbes and viruses are becoming ever-resistant to antibiotics and other treatments .And where ‘superbugs’ are no longer sci-fi medical concepts but very real problems inside hospitals everywhere, making staph infections look like a breeze in comparison.As the human population rises and urban centres grow denser and denser while international and domestic travel routes become more and more efficient, the threat of disease is only going to become more and more relevant to our day-to-day lives.Believe me – this finance journalist is just as keen as you are to avoid thinking about the fact we might ever see lockdowns in our lives again.But, the reality is, the risk is there. Viruses are, after all, more ancient than the human race. And they’ll probably outlive us.And, Firebrick’s Nasodine product is already available in the world’s number one economy: The United States","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/history-tells-us-therell-be-another-pandemic-given-that-has-firebrick-pharma-been-wildly-overlooked-2024-12-12/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2486743534","title":"Firebrick Pharma launching retail Nasodine sales in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2486743534","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486743534?lang=en_us&edition=fundamental","pubTime":"2024-11-25 08:07","pubTimestamp":1732493220,"startTime":"0","endTime":"0","summary":"Firebrick Pharma has inked a deal with Guardian, a pharmacy chain in Singapore, to launch retail sales of its Nasodine product.The antiseptic nasal spray – think ‘Betadine’ when it comes to the name – has been the company’s flagship offering for a while now, advertises on its website as “the spray that kills germs.”The spray does not necessarily target any one condition but instead lends itself to being a nasal spray analogue for alcoholic hand wash.It’s more about satisfying potential user concerns after spending time on public transport and in office buildings, for example, one could be exposing oneself to other people’s germs – an interesting product to watch.Firebrick expects its Nasodine to be available in all of Guardian’s 121 stores across Singapore –including, the company specifically highlighted, 6 at Changi Airport.“Firebrick management will assist in the training of Guardian retail pharmacists to sell Nasodine to consumers,” the company wrote on Monday.Join the discussion: ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/firebrick-pharma-launching-retail-nasodine-sales-in-singapore-2024-11-25/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2486133711","title":"Firebrick Pharma Ltd-Nasodine Retail Pharmacy Launch in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2486133711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486133711?lang=en_us&edition=fundamental","pubTime":"2024-11-25 05:22","pubTimestamp":1732483375,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241124:nTUE58MCFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2480010015","title":"Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480010015","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480010015?lang=en_us&edition=fundamental","pubTime":"2024-11-01 10:46","pubTimestamp":1730429206,"startTime":"0","endTime":"0","summary":"Firebrick Pharma received notice of allowance of Nasodine's COVID-19 patent in Mexico, according to a Friday filing with the Australian bourse.The patent protects the use of Nasodine nasal spray and any other intranasal povidone-iodine preparations as a method of reducing the viral load of SARS-CoV-2 in the nose, the filing stated.The patent is already granted in the US, Australia, and South Africa, with applications in other countries still pending.Firebrick Pharma's shares were up nearly 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","XAO.AU","XKO.AU","FRE.AU","XJO.AU","BNTX"],"gpt_icon":0},{"id":"2480201377","title":"BRIEF-Firebrick Pharma Says Nasodine Covid-19 Patent Allowed In Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480201377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480201377?lang=en_us&edition=fundamental","pubTime":"2024-11-01 08:55","pubTimestamp":1730422537,"startTime":"0","endTime":"0","summary":"Nov 1 (Reuters) - Firebrick Pharma Ltd : * NASODINE COVID-19 PATENT ALLOWED IN MEXICO Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2480096465","title":"Firebrick Pharma - Nasodine Covid-19 Patent Allowed in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480096465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480096465?lang=en_us&edition=fundamental","pubTime":"2024-11-01 06:38","pubTimestamp":1730414290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nFWN3M71OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2479718491","title":"BRIEF-Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2479718491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479718491?lang=en_us&edition=fundamental","pubTime":"2024-10-31 09:31","pubTimestamp":1730338304,"startTime":"0","endTime":"0","summary":"Oct 31 (Reuters) - Firebrick Pharma Ltd : * AGREEMENT SIGNED TO MARKET NASODINE TO HEALTHCARE PROFESSIONALS IN SINGAPORESource text: Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2479761035","title":"Firebrick Pharma Ltd - Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2479761035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479761035?lang=en_us&edition=fundamental","pubTime":"2024-10-31 05:41","pubTimestamp":1730324515,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2474756780","title":"Firebrick Pharma Raises Capital via Share Purchase Plan; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474756780","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474756780?lang=en_us&edition=fundamental","pubTime":"2024-10-10 11:48","pubTimestamp":1728532110,"startTime":"0","endTime":"0","summary":"Firebrick Pharma raised around AU$800,000 via a share purchase plan at AU$0.055 apiece, according to a Thursday filing with the Australian bourse.The pharmaceutical firm raised AU$635,600 following the completion of its share purchase plan comprising the issue of roughly 11.6 million fully paid ordinary shares.Further, the company received commitments or applications for an additional AU$158,700 worth of shares. Settlement is expected to occur by Oct. 15.Proceeds will be used to fund Firebrick Pharma's marketing initiatives for Nasodine nasal spray in Singapore and the US, the filing stated.Firebrick Pharma's shares were up more than 7% in recent trade.Price : $0.06, Change: $+0.0040, Percent Change: +7.27%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","FRE.AU","AUD","BK4125"],"gpt_icon":0},{"id":"2472494663","title":"Firebrick Pharma Ltd-Firebrick Investor Update Webinar Recording","url":"https://stock-news.laohu8.com/highlight/detail?id=2472494663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472494663?lang=en_us&edition=fundamental","pubTime":"2024-10-01 17:03","pubTimestamp":1727773435,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nTUE5KTGHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2470856652","title":"Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2470856652","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470856652?lang=en_us&edition=fundamental","pubTime":"2024-09-25 15:00","pubTimestamp":1727247621,"startTime":"0","endTime":"0","summary":"Australian shares were flat with a negative bias on Wednesday following a report showing that the domestic consumer price index slowed to its lowest point in three years.The S&P/ASX 200 index was litt","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","SIG.AU","FRE.AU","XKO.AU","BK7096","BK7083","XJO.AU","ERA.AU","BK4137","BK7103","XAO.AU"],"gpt_icon":0},{"id":"2470408064","title":"Firebrick Pharma Eyes Global Expansion for Nasodine Nasal Spray; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470408064","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470408064?lang=en_us&edition=fundamental","pubTime":"2024-09-25 11:41","pubTimestamp":1727235693,"startTime":"0","endTime":"0","summary":"Firebrick Pharma intends to get its Nasodine nasal spray approved in all markets over the long term to receive royalties and license fees through its partners, according to a Wednesday filing with the Australian bourse.In its investor update, Firebrick Pharma said it expects a decision on its application for Nasodine to be marketed as a nasal antiseptic in Europe in 2025. Once approved, the company plans to lodge its application in New Zealand and South Africa.Nasodine is being marketed as a nasal cleanser in the US, where the company plans to pursue pharmacy distribution.In the Philippines, the product is expected to be launched as a nasal antiseptic in 2025.The pharmaceutical company's shares were up nearly 8% in recent Wednesday trade.Price : $0.06, Change: $+0.004, Percent Change: +7.69%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","AUD","BK4125","FRE.AU"],"gpt_icon":0},{"id":"2468386405","title":"Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468386405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468386405?lang=en_us&edition=fundamental","pubTime":"2024-09-17 13:45","pubTimestamp":1726551927,"startTime":"0","endTime":"0","summary":"Firebrick Pharma opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.Price : $0.05, Change: $-0.0020, Percent Change: -3.57%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","FRE.AU","BK4125","AUD","XAO.AU","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2468780310","title":"Firebrick Pharma Ltd-Share Purchase Plan Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2468780310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468780310?lang=en_us&edition=fundamental","pubTime":"2024-09-17 09:16","pubTimestamp":1726535812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240917:nTUE5RQSZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2466291885","title":"BRIEF-Firebrick Pharma Announces Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2466291885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466291885?lang=en_us&edition=fundamental","pubTime":"2024-09-12 09:28","pubTimestamp":1726104532,"startTime":"0","endTime":"0","summary":"Sept 12 (Reuters) - Firebrick Pharma Ltd : * SHARE PURCHASE PLAN AT AN ISSUE PRICE OF A$0.055 PER SHARE * INTENDS TO RAISE UP TO A$2 MILLION PURSUANT TO SPPFurther company coverage: ((Reuters.Briefs@thomsonreuters.com;;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2466229667","title":"BUZZ-Australia's Firebrick Pharma tumbles on discounted share purchase plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2466229667","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466229667?lang=en_us&edition=fundamental","pubTime":"2024-09-12 09:02","pubTimestamp":1726102922,"startTime":"0","endTime":"0","summary":"** Shares of Firebrick Pharma fall as much as 9.2% to A$0.059, posting their biggest intraday percentage decline since May 28 ** Stock hits its lowest level since Aug 21 ** Pharmaceutical co says it will raise up to A$2 mln via share purchase plan at A$0.055 per share ** Issue price represents a 15.4% discount on co's last close ** About 986,000 shares change hands, compared with the 30-day average volume of around 102,000 ** Stock up 18% YTD, including session's move ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","XKO.AU","BK7096","XJO.AU","FRE.AU"],"gpt_icon":0},{"id":"2466126704","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466126704","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466126704?lang=en_us&edition=fundamental","pubTime":"2024-09-12 07:46","pubTimestamp":1726098401,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Alto Metals (ASX:AME)Alto Metals started a reverse circulation drilling program at it","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","EQN.AU","XAO.AU","HRZ.AU","XJO.AU","CHW.AU","BK7095","XKO.AU","FRE.AU","BRX.AU","BK7129","AME.AU","BM8.AU","BK7104"],"gpt_icon":0},{"id":"2466075267","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466075267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466075267?lang=en_us&edition=fundamental","pubTime":"2024-09-12 07:46","pubTimestamp":1726098401,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4585","XKO.AU","XAO.AU","XJO.AU","MTX","BK4211","CHW","HRZ.AU","BK7129","ISBC","BK4588","BK4096","BK7096","BRX.AU","BK7504","BK4168","BM8.AU","FRE.AU","BK7507","BK4080","BRX","EQN.AU","AME","PLS.AU","BK4231","AME.AU","CHW.AU","BK4109","BK7104","BK7095","WRN"],"gpt_icon":0},{"id":"2466526926","title":"Firebrick Pharma Ltd - Share Purchase Plan at an Issue Price of a$0.055 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2466526926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466526926?lang=en_us&edition=fundamental","pubTime":"2024-09-12 06:22","pubTimestamp":1726093338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nFWN3KT0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.037},{"period":"3month","weight":0},{"period":"6month","weight":-0.0175},{"period":"1year","weight":0.098},{"period":"ytd","weight":0.12}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":0.0301},{"period":"3month","weight":-0.0008},{"period":"6month","weight":0.0431},{"period":"1year","weight":0.1557},{"period":"ytd","weight":0.1495}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.132867},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.024129},{"month":3,"riseRate":0.333333,"avgChangeRate":0.070505},{"month":4,"riseRate":0,"avgChangeRate":-0.098795},{"month":5,"riseRate":0,"avgChangeRate":-0.142958},{"month":6,"riseRate":0.666667,"avgChangeRate":0.105958},{"month":7,"riseRate":0.666667,"avgChangeRate":0.354354},{"month":8,"riseRate":0,"avgChangeRate":-0.356944},{"month":9,"riseRate":0,"avgChangeRate":-0.1193},{"month":10,"riseRate":0.333333,"avgChangeRate":0.172515},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.07293},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011739}],"exchange":"ASX","name":"FIREBRICK PHARMA LTD","nameEN":"FIREBRICK PHARMA LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FIREBRICK PHARMA LTD(FRE.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest FIREBRICK PHARMA LTD(FRE.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"FIREBRICK PHARMA LTD,FRE.AU,FIREBRICK PHARMA LTD股票,FIREBRICK PHARMA LTD股票老虎,FIREBRICK PHARMA LTD股票老虎国际,FIREBRICK PHARMA LTD行情,FIREBRICK PHARMA LTD股票行情,FIREBRICK PHARMA LTD股价,FIREBRICK PHARMA LTD股市,FIREBRICK PHARMA LTD股票价格,FIREBRICK PHARMA LTD股票交易,FIREBRICK PHARMA LTD股票购买,FIREBRICK PHARMA LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FIREBRICK PHARMA LTD(FRE.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest FIREBRICK PHARMA LTD(FRE.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}